How does low HDL affect my heart health?

Low HDL cholesterol increases cardiovascular disease risk by reducing the body's ability to remove harmful cholesterol from arteries. Maintaining HDL levels above 40 mg/dL for men and 50 mg/dL for women is crucial for heart protection.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

High-density lipoprotein (HDL) cholesterol, often called "good cholesterol," plays a crucial role in protecting your cardiovascular system. Unlike its counterpart LDL cholesterol, which can contribute to arterial plaque buildup, HDL cholesterol works as your body's cleanup crew, transporting cholesterol away from your arteries and back to your liver for disposal. When HDL levels drop too low, this protective mechanism becomes compromised, significantly increasing your risk of heart disease and stroke.

Understanding HDL Cholesterol and Its Protective Role

HDL cholesterol functions as a molecular transport system that removes excess cholesterol from your arterial walls and peripheral tissues. This process, known as reverse cholesterol transport, is one of your body's primary defenses against atherosclerosis—the buildup of fatty plaques in your arteries that can lead to heart attacks and strokes.

How HDL Protects Your Arteries

HDL particles act like microscopic vacuum cleaners in your bloodstream. They bind to cholesterol deposits in your arterial walls and transport them to your liver, where the cholesterol is either recycled into bile acids or eliminated from your body. This process helps prevent the formation of atherosclerotic plaques that can narrow your arteries and restrict blood flow to vital organs.

HDL Cholesterol Level Classifications

HDL Level (mg/dL)MenWomenCardiovascular Risk
Low Risk≥60ProtectiveProtectiveReduced risk
Acceptable40-59Acceptable50-59Average risk
Low<40Low40-49Increased risk
Very Low<35Very Low<40High risk

HDL cholesterol levels and associated cardiovascular risk categories for men and women.

Beyond cholesterol removal, HDL also provides additional cardiovascular benefits. It has anti-inflammatory properties that help reduce arterial inflammation, antioxidant effects that protect against oxidative stress, and anticoagulant properties that may help prevent blood clots.

What Constitutes Low HDL Levels

According to the American Heart Association and National Cholesterol Education Program, HDL cholesterol levels are classified as follows for adults. Understanding these ranges helps you assess your cardiovascular risk and take appropriate action.

Research suggests that for every 1 mg/dL increase in HDL cholesterol, cardiovascular disease risk decreases by approximately 2-3%. This inverse relationship makes HDL one of the most important biomarkers for assessing heart health.

The Cardiovascular Risks of Low HDL

Low HDL cholesterol significantly increases your risk of developing cardiovascular disease, even when other cholesterol levels appear normal. The Framingham Heart Study, one of the longest-running cardiovascular research projects, found that people with HDL levels below 40 mg/dL had a 50% higher risk of heart disease compared to those with higher levels.

Increased Atherosclerosis Risk

When HDL levels are low, your body's ability to remove cholesterol from arterial walls becomes impaired. This allows LDL cholesterol and other atherogenic particles to accumulate more easily in your arteries, accelerating the development of atherosclerotic plaques. These plaques can grow over time, narrowing your arteries and reducing blood flow to your heart, brain, and other organs.

The relationship between low HDL and atherosclerosis is particularly concerning because it creates a compounding effect. As HDL levels decrease, not only does cholesterol removal slow down, but the anti-inflammatory and antioxidant benefits of HDL are also reduced, creating an environment more conducive to plaque formation and progression.

Heart Attack and Stroke Risk

Low HDL cholesterol is an independent risk factor for both heart attacks and strokes. The INTERHEART study, which analyzed data from over 29,000 participants across 52 countries, found that low HDL was one of the nine most significant modifiable risk factors for heart attack, regardless of geographic location or ethnicity.

People with HDL levels below 35 mg/dL have approximately twice the risk of heart attack compared to those with levels above 65 mg/dL. This risk persists even when LDL cholesterol levels are within normal ranges, highlighting the independent importance of maintaining adequate HDL levels.

Common Causes of Low HDL Cholesterol

Understanding what causes low HDL cholesterol can help you identify modifiable factors and work with your healthcare provider to develop an effective treatment strategy. Both lifestyle factors and genetic predisposition can contribute to low HDL levels.

Lifestyle Factors

Several lifestyle factors can significantly impact your HDL cholesterol levels:

  • Sedentary lifestyle: Physical inactivity is one of the strongest predictors of low HDL cholesterol
  • Poor diet: Diets high in refined carbohydrates and trans fats can suppress HDL production
  • Excess weight: Obesity, particularly abdominal obesity, is associated with lower HDL levels
  • Smoking: Tobacco use can reduce HDL cholesterol by 10-15%
  • Excessive alcohol consumption: While moderate alcohol intake may raise HDL, excessive drinking can have the opposite effect

Medical Conditions and Medications

Certain medical conditions and medications can also contribute to low HDL cholesterol:

  • Type 2 diabetes and insulin resistance
  • Metabolic syndrome
  • Hypothyroidism
  • Chronic kidney disease
  • Certain medications including beta-blockers, anabolic steroids, and some diuretics

Regular monitoring of your cholesterol profile, including HDL levels, is essential for identifying these issues early and taking appropriate action to protect your cardiovascular health.

Strategies to Raise HDL Cholesterol Naturally

The good news is that HDL cholesterol levels can often be improved through lifestyle modifications. Research shows that comprehensive lifestyle changes can increase HDL cholesterol by 15-25%, providing significant cardiovascular protection.

Exercise and Physical Activity

Regular physical activity is one of the most effective ways to raise HDL cholesterol. Aerobic exercise, in particular, has been shown to increase HDL levels by 5-10% in most people. The key is consistency and intensity—aim for at least 150 minutes of moderate-intensity exercise or 75 minutes of vigorous-intensity exercise per week.

High-intensity interval training (HIIT) may be particularly effective for raising HDL cholesterol. Studies have shown that HIIT can increase HDL levels more than traditional steady-state cardio, possibly due to its effects on fat metabolism and insulin sensitivity.

Dietary Modifications

Your diet plays a crucial role in HDL cholesterol levels. Focus on these evidence-based dietary strategies:

  • Increase omega-3 fatty acids from fatty fish, walnuts, and flaxseeds
  • Choose healthy fats like olive oil, avocados, and nuts over saturated and trans fats
  • Reduce refined carbohydrates and added sugars
  • Include soluble fiber from oats, beans, and vegetables
  • Consider moderate alcohol consumption if appropriate (1 drink per day for women, 2 for men)

The Mediterranean diet pattern has been particularly well-studied for its effects on HDL cholesterol and overall cardiovascular health. This eating pattern emphasizes whole foods, healthy fats, and moderate alcohol consumption while limiting processed foods and refined sugars.

When to Consider Medical Treatment

While lifestyle modifications are the first line of treatment for low HDL cholesterol, some people may need additional medical intervention. Your healthcare provider may recommend medication if your HDL remains low despite lifestyle changes, especially if you have other cardiovascular risk factors.

Medication Options

Several medications can help raise HDL cholesterol levels, though they're typically reserved for high-risk patients. These include niacin (nicotinic acid), fibrates, and certain statins that have modest HDL-raising effects. However, recent research has questioned whether raising HDL through medication provides the same cardiovascular benefits as naturally higher HDL levels.

The focus has shifted toward comprehensive cardiovascular risk management rather than targeting HDL levels alone. This approach considers your overall lipid profile, including LDL cholesterol, triglycerides, and advanced markers like apolipoprotein B (ApoB).

Comprehensive Risk Assessment

Modern cardiovascular risk assessment goes beyond traditional cholesterol numbers to include advanced biomarkers and risk calculators. Your healthcare provider may use tools like the Pooled Cohort Equations or consider additional factors such as family history, inflammatory markers, and coronary artery calcium scores to determine your overall risk and treatment strategy.

Understanding your complete cardiovascular risk profile helps guide treatment decisions and ensures you receive the most appropriate interventions for your individual situation. Regular monitoring through comprehensive lipid panels allows for timely adjustments to your treatment plan as needed.

Monitoring Your Progress and Long-term Management

Successfully managing low HDL cholesterol requires ongoing monitoring and adjustment of your treatment strategy. Regular testing allows you to track your progress and make necessary modifications to your lifestyle or treatment plan.

Most healthcare providers recommend checking cholesterol levels every 3-6 months when actively working to improve HDL levels, then annually once levels stabilize. This frequency allows for timely adjustments to your approach while avoiding unnecessary testing.

Keep in mind that HDL cholesterol levels can fluctuate based on various factors, including recent illness, stress, dietary changes, and exercise patterns. Consistent lifestyle habits and regular monitoring help ensure that your efforts to raise HDL cholesterol translate into long-term cardiovascular protection.

Remember that improving HDL cholesterol is just one component of comprehensive cardiovascular health. Maintaining healthy blood pressure, managing stress, avoiding tobacco, and controlling other risk factors are equally important for protecting your heart and reducing your risk of cardiovascular disease.

References

  1. Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977). High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. The American Journal of Medicine, 62(5), 707-714.[PubMed]
  2. Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., ... & INTERHEART Study Investigators. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet, 364(9438), 937-952.[PubMed]
  3. Kodama, S., Tanaka, S., Saito, K., Shu, M., Sone, Y., Onitake, F., ... & Sone, H. (2007). Effect of aerobic exercise training on serum levels of high-density lipoprotein cholesterol: a meta-analysis. Archives of Internal Medicine, 167(10), 999-1008.[PubMed]

Was this article helpful?

Frequently Asked Questions

How can I test my HDL cholesterol at home?

You can test your HDL cholesterol at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes comprehensive cholesterol testing, including HDL, LDL, triglycerides, and advanced markers like ApoA1 and ApoB, providing lab-quality results from the comfort of your home.

What is considered a dangerously low HDL level?

HDL levels below 40 mg/dL for men and below 50 mg/dL for women are considered low and increase cardiovascular disease risk. Levels below 35 mg/dL are particularly concerning and may require immediate medical attention and aggressive lifestyle interventions.

How quickly can I raise my HDL cholesterol naturally?

With consistent lifestyle changes including regular exercise and dietary modifications, you may see improvements in HDL cholesterol within 6-12 weeks. However, significant changes typically take 3-6 months of sustained effort, and individual responses vary based on genetics and baseline levels.

Can low HDL cholesterol be genetic?

Yes, genetics play a significant role in HDL cholesterol levels. Some people have genetic variants that predispose them to lower HDL levels, while others may have familial conditions like Tangier disease that severely affect HDL metabolism. However, lifestyle factors can still influence HDL levels even with genetic predisposition.

Is it possible to have too high HDL cholesterol?

While higher HDL levels are generally protective, extremely high levels (above 100 mg/dL) may sometimes indicate underlying health issues or genetic conditions. Most research shows continued cardiovascular benefits with higher HDL levels, but it's important to consider your overall lipid profile and health status.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details